Genome Solutions Has Been Granted BioNexus Status by the Malaysian Government

Kuala Lumpur, Malaysia, 9th March 2015 - We are pleased to announce that Genome Solutions has been granted BioNexus Status by the Malaysian Biotechnology Corp Sdn Bhd (BiotechCorp), a national agency established by the government to support the development of the Malaysian biotechnology industry. BioNexus is a special recognition awarded by BiotechCorp to qualified local and international biotechnology companies that participate in value-added biotechnology activities. The status endows fiscal incentives, grants and other guarantees to assist growth. Among of these incentives are exemption from 100% statutory income, double deduction on expenditure incurred for R&D and export promotion, companies investing in a BioNexus Status company are granted tax deductions equivalent to the level of investment, and are exempt from sales tax and import duty on raw components/materials and machinery/equipment.

We appreciate the strong vote of confidence from the Malaysian government in our business. This award is indeed a key milestone for Genome Solutions. As a BioNexus Status company, Genome Solutions can enjoy a set of incentives, privileges, continuous support and assistance from the Malaysian government that are important for its expansion in Malaysia and globally.

About Genome Solutions

Genome Solutions is a bioinformatics and biomedical company based in the University of Malaya, Kuala Lumpur, Malaysia. Its core business is to provide genomic services and bioinformatics solutions to scientists from academia and industry. With many years of extensive experience and a strong team of specialists, Genome Solutions supports clients both locally and globally to achieve their project goals in faster and smarter ways. Genome Solutions offers a wide range of genomic research services focussed on activities which are important for their clients. Genome Solutions is also actively involved in R&D to keep abreast of new developments and trends in this fast-growing market.


Genome Solutions Sdn Bhd
Emily Choo